Precision BioSciences Strengthens Board of Directors with Appointment of Geno Germano

NEXT STORY
LexaGene Provides Corporate Update
PREV STORY
Teleflex Celebrates 175,000 Patients Treated with the UroLift® System
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

FDA approves Shire’s Motegrity™ (prucalopride), the only serotonin-4 receptor agonist for adults with Chronic Idiopathic Constipation (CIC)

 Intended for U.S. Audience FDA approves Shire’s Motegrity™ (prucalopride), the only serotonin-4 receptor agonist ...

author_avatar
NASDAQ Market News

Century Therapeutics Announces Its Addition to the Russell 2000® Index

author_avatar
NASDAQ Market News

Multiverse Investment Fund Announces Portfolio Company’s Commencement of Clinical Trials to Treat Acute Respiratory Distress Syndrome (ARDS) Caused by Coronavirus (COVID-19)

author_avatar
NASDAQ Market News